Head & Neck Cancer Clinical Trials
To Participate in any of these clinical trials or for more information:
Call us at (808) 586-2979
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Study Number | Study Details |
|---|---|
ECOG-ACRIN-EA3202 Local Principal Investigator: | Official Title: A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers Enrollment Status: Open: HCC, QMC Opt out: HPH Cancer Type: Head & Neck Keywords: Advanced / Recurrent Subtype: Head & Neck ClinicalTrials.gov ID: NCT05063552 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
SWOG-S2101 Local Principal Investigator: | Official Title: Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants With Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study Enrollment Status: Temporarily Closed to Accrual as of 08/15/2024 Cancer Type: Head & Neck Keywords: Advanced Subtype: Head & Neck ClinicalTrials.gov ID: NCT05136196 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
WF-1805CD Local Principal Investigator: | Official Title: Implementation and Effectiveness Trial of HN-STAR Enrollment Status: Open: QMC only Cancer Type: Head & Neck Keywords: HN-STAR Subtype: Head & Neck Survivorship ClinicalTrials.gov ID: NCT04208490 Visit ClinicalTrials.gov for Complete Trial Details and Eligibility Requirements |
